Application Details

2015 LUNGevity Awards for Translational Research

LUNGevity has issued three Requests for Application (RFAs) for translational lung cancer research awards:

  • Career Development Awards
  • Early Detection Awards
  • Targeted Therapeutics Awards

Career Development Awards

LUNGevity’s Career Development Awards for Translational Research program was created to support future research leaders who will keep the field of lung cancer research vibrant with new ideas. Applicants must be within the first five years of their faculty appointment. The Career Development Awards are mentored awards; a mentoring plan is part of the required submission.

Projects that will be funded in 2015 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment, including through immuno-oncology.

Career Development Awards may be for a maximum of $100,000 per year for three years, for a maximum award of $300,000.

Note: LUNGevity will grant only one Career Development Award application per institution.

Letters of intent must be submitted by Friday, December 12, 2014. Those invited to proceed will be notified no earlier than Friday, January 16, 2015, and must submit a full application by Friday, March 13, 2015.

Letters of intent and full applications must be submitted electronically via proposalCENTRAL.

For a copy of the RFA, which includes complete instructions and a timeline, click here or visit https://proposalcentral.altum.com.

Early Detection Awards

2015 LUNGevity research funds will be awarded to support research projects directed at new approaches to improved clinical methods for the detection and diagnosis of primary tumors. Projects are expected to have a direct impact on the early detection and/or diagnosis of lung cancer or a clear conceptual or experimental foundation for the future development of methods for early detection.

Applicants may apply as individuals or in teams of two or more principal investigators. It is strongly encouraged that teams be composed of principal investigators from different institutions.

Early Detection Awards may be for a maximum of $200,000 over two to three years for an individual principal investigator, and up to $600,000 over two to three years for a multidisciplinary team of two or more principal investigators.

Letters of intent must be submitted by Friday, December 12, 2014. Those invited to proceed will be notified no earlier than Friday, January 16, 2015, and must submit a full application by Friday, March 13, 2015.

Letters of intent and full applications must be submitted electronically via proposalCENTRAL.

For a copy of the RFA, which includes complete instructions and a timeline, click here or visit https://proposalcentral.altum.com.

Targeted Therapeutics Awards

2015 LUNGevity research funds will be awarded to support research projects directed at targeted therapeutics, including immuno-oncology, that will make a difference in the clinical treatment and survival of patients.

Applicants may apply as individuals or in teams of two or more principal investigators. It is strongly encouraged that teams be composed of principal investigators from different institutions.

Targeted Therapeutics Awards may be for a maximum of $200,000 over two to three years for an individual principal investigator, and up to $600,000 over two to three years for a multidisciplinary team of two or more principal investigators.

Letters of intent must be submitted by Friday, December 12, 2014. Those invited to proceed will be notified no earlier than Friday, January 16, 2015, and must submit a full application by Friday, March 13, 2015.

Letters of intent and full applications must be submitted electronically via proposalCENTRAL.

For a copy of the RFA, which includes complete instructions and a timeline, click here or visit https://proposalcentral.altum.com.